News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,030 Results
Type
Article (40069)
Company Profile (272)
Press Release (660689)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (205259)
Career Advice (2020)
Deals (35556)
Drug Delivery (97)
Drug Development (81281)
Employer Resources (172)
FDA (16232)
Job Trends (14915)
News (346724)
Policy (32664)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2575)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49827)
ALS (86)
Alzheimer's disease (1373)
Antibody-drug conjugate (ADC) (115)
Approvals (16233)
Artificial intelligence (244)
Autoimmune disease (21)
Automation (15)
Bankruptcy (365)
Best Places to Work (11665)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (191)
Bladder cancer (61)
Brain cancer (26)
Breast cancer (265)
Cancer (2092)
Cardiovascular disease (168)
Career advice (1686)
Career pathing (29)
CAR-T (144)
Cell therapy (408)
Cervical cancer (19)
Clinical research (66007)
Collaboration (806)
Compensation (508)
Complete response letters (19)
COVID-19 (2600)
CRISPR (38)
C-suite (224)
Cystic fibrosis (100)
Data (2052)
Decentralized trials (2)
Denatured (19)
Depression (39)
Diabetes (258)
Diagnostics (6385)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (118)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (86493)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (112505)
Executive appointments (699)
FDA (17420)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (726)
Gene editing (102)
Generative AI (20)
Gene therapy (286)
GLP-1 (705)
Government (4421)
Grass and pollen (4)
Guidances (51)
Healthcare (18856)
Huntington's disease (24)
IgA nephropathy (24)
Immunology and inflammation (113)
Indications (27)
Infectious disease (2741)
Inflammatory bowel disease (137)
Inflation Reduction Act (10)
Influenza (50)
Intellectual property (92)
Interviews (311)
IPO (16535)
IRA (42)
Job creations (3666)
Job search strategy (1434)
Kidney cancer (9)
Labor market (36)
Layoffs (467)
Leadership (16)
Legal (7943)
Liver cancer (72)
Lung cancer (302)
Lymphoma (139)
Machine learning (5)
Management (58)
Manufacturing (283)
MASH (62)
Medical device (13394)
Medtech (13399)
Mergers & acquisitions (19534)
Metabolic disorders (665)
Multiple sclerosis (75)
NASH (16)
Neurodegenerative disease (84)
Neuropsychiatric disorders (24)
Neuroscience (1881)
NextGen: Class of 2025 (6560)
Non-profit (4493)
Northern California (2540)
Now hiring (38)
Obesity (356)
Opinion (207)
Ovarian cancer (73)
Pain (81)
Pancreatic cancer (81)
Parkinson's disease (146)
Partnered (21)
Patents (222)
Patient recruitment (99)
Peanut (46)
People (57605)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20575)
Phase II (29056)
Phase III (21668)
Pipeline (1115)
Policy (133)
Postmarket research (2566)
Preclinical (8712)
Press Release (64)
Prostate cancer (98)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (373)
Real estate (5964)
Recruiting (65)
Regulatory (22297)
Reports (46)
Research institute (2331)
Resumes & cover letters (350)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (65)
Series A (127)
Series B (81)
Service/supplier (13)
Sickle cell disease (54)
Southern California (2190)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3637)
State (2)
Stomach cancer (13)
Supply chain (65)
Tariffs (24)
The Weekly (30)
United States (22085)
Vaccines (670)
Venture capitalists (40)
Weight loss (234)
Women's health (34)
Worklife (15)
Date
Today (2)
Last 7 days (471)
Last 30 days (2227)
Last 365 days (32949)
2025 (9245)
2024 (35381)
2023 (40216)
2022 (51331)
2021 (55879)
2020 (54204)
2019 (46719)
2018 (35170)
2017 (32272)
2016 (31674)
2015 (37761)
2014 (31487)
2013 (26536)
2012 (28799)
2011 (29476)
2010 (27569)
Location
Africa (721)
Alabama (52)
Alaska (7)
Arizona (229)
Arkansas (13)
Asia (38070)
Australia (6234)
California (5802)
Canada (1941)
China (490)
Colorado (255)
Connecticut (262)
Delaware (134)
Europe (81706)
Florida (860)
Georgia (202)
Idaho (58)
Illinois (516)
India (26)
Indiana (302)
Iowa (9)
Japan (149)
Kansas (103)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (858)
Massachusetts (4354)
Michigan (215)
Minnesota (379)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (63)
New Jersey (1661)
New Mexico (30)
New York (1651)
North Carolina (941)
North Dakota (7)
Northern California (2540)
Ohio (196)
Oklahoma (14)
Oregon (34)
Pennsylvania (1307)
Puerto Rico (11)
Rhode Island (31)
South America (1100)
South Carolina (20)
South Dakota (1)
Southern California (2190)
Tennessee (99)
Texas (865)
Utah (171)
Virginia (136)
Washington D.C. (60)
Washington State (533)
West Virginia (3)
Wisconsin (51)
701,030 Results for "flagship biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Flagship’s AI Company Generate Inks Deal Worth up to $1B With Novartis
Flagship Pioneering–backed Generate:Biomedicines has signed its second major Big Pharma partnership, bringing in $65 million upfront to use its AI platform to discover novel protein drug candidates.
September 24, 2024
·
2 min read
·
Annalee Armstrong
Collaboration
Pfizer Partners With Flagship’s Quotient to Leverage Genetics Against Heart, Renal Diseases
Quotient Therapeutics’ platform targets somatic mutations, which the startup contends can help identify a broader scope of genes potentially associated with disease phenotypes. Wednesday’s agreement is part of an existing partnership between Pfizer and Flagship Pioneering.
August 28, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease
April 1, 2025
·
3 min read
Press Releases
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD
February 18, 2025
·
5 min read
Press Releases
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 2, 2025
·
2 min read
Press Releases
Xenetic Biosciences, Inc. Releases Virtual Investor “What This Means” Segment
April 10, 2025
·
5 min read
Business
Pfizer, Flagship Pioneering to Target Obesity Treatments Under 2023 Partnership
Building on last year’s potential $7 billion partnership with Flagship Pioneering, Pfizer and Flagship-founded ProFound Therapeutics will work on discovering new obesity candidates.
June 12, 2024
·
2 min read
·
Tyler Patchen
Business
GSK, Flagship Commit $150M Upfront for Initial Development of Respiratory, Immunology Programs
Flagship Pioneering and its portfolio companies are in line to receive up to $720 million in milestones for each of the 10 programs that GSK could option, according to Monday’s announcement.
July 30, 2024
·
2 min read
·
Nick Paul Taylor
Press Releases
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
March 31, 2025
·
7 min read
Press Releases
Accord BioPharma, Inc. Announces Completion of UDENYCA® (pegfilgrastim-cbqv) Franchise Acquisition from Coherus BioSciences, Inc., Expanding U.S. Biosimilar Portfolio
April 14, 2025
·
9 min read
1 of 70,103
Next
